Categories: Launches

Lupin launches Fluoxetine Tablets USP

Mumbai, April 10, 2019: Pharma major Lupin Limited (Lupin) announced the launch of Fluoxetine Tablets USP, 60mg, having received an approval from the United States Food and Drug Administration (FDA) earlier.

Lupin’s Fluoxetine Tablets USP, 60mg, is the generic version of Alvogen Group Holdings 3 LLC’s Fluoxetine Tablets, 60mg. It is indicated in the treatment of:

  • Major Depressive Disorder (MDD)

Adults: Efficacy was established in one 5-week trial, three 6-week trials, and one maintenance study Pediatrics: Efficacy was established in two 8- to 9-week trials of patients 8 to 18 years of age

  • Obsessive Compulsive Disorder (OCD)

Adults: Efficacy was established in two 13-week trials

Pediatrics: Efficacy was established in one 13-week trial in pediatric patients 7 to 17 years of age

  • Bulimia Nervosa

Adults: Efficacy was established in two 8-week trials and one 16-week trial

  • Panic disorder, with or without agoraphobia

Adults: Efficacy was established in two 12-week trials

Fluoxetine Tablets, 60mg, had annual sales of approximately USD 41 million in the US (IQVIA MAT February 2019).

Corporate Comm India(CCI Newswire)

The Pharma Times News Bureau

Recent Posts

Arya Vaidya Pharmacy Expands Product Portfolio, Strengthening Its Commitment to Holistic Health and Sustainability

New Delhi, January 10, 2025: Arya Vaidya Pharmacy (Coimbatore) Ltd. (AVP), a pioneer in Ayurvedic healthcare…

2 days ago

The future of healthcare: Five key trends for providers in 2025

By Srinath Rao, Senior Vice President, CitiusTech A few decades back, the purpose of watches…

4 days ago

Switzerland’s Basel Region Crowned ‘Europe’s Top Destination to Launch a Drug Device Company’, According to Pharmapack Report

Pharmapack Europe: 'Basel the best location for drug device innovation in Europe thanks to combination…

4 days ago

Quote on HMPV by Doctors of Super Specialty Hospitals

New Delhi, January 07, 2025: HMP virus can travel to the brain, or it can…

5 days ago

Advisory For Hmpv – Key Preventative Measures

~ Co-authored by Dr Sanjith Saseedharan, Director-Critical Care, S. L. Raheja Hospital- A Fortis Associate…

5 days ago

40% of Doctor Appointments Dedicated to Family and Friends, Reveals MediBuddy’s 2024 Data

Patients Embrace Flexibility with 37% of Online Doctor Consultations now happening even After 6 PM,…

6 days ago